340 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
AGN Allergan plc. $184.29 $62.56B N/A
Article Searches
Allergan (AGN) to Report Q2 Earnings: What's in the Cards? http://www.zacks.com/stock/news/312762/allergan-agn-to-report-q2-earnings-whats-in-the-cards?cid=CS-ZC-FT-312762 Jul 23, 2018 - While Allergan's (AGN) Q2 sales are likely to be driven by new as well as established products like Botox and international growth, generic competition for some key products is expected to hurt sales.
Allergan (AGN) Abicipar SEQUOIA & CEDAR Phase 3 Study Results - Slideshow https://seekingalpha.com/article/4188473-allergan-agn-abicipar-sequoia-and-cedar-phase-3-study-results-slideshow?source=feed_sector_healthcare Jul 19, 2018 - The following slide deck was published by Allergan plc in conjunction with this event.
AGN or TLGT: Which Is the Better Value Stock Right Now? http://www.zacks.com/stock/news/312256/agn-or-tlgt-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-312256 Jul 19, 2018 - AGN vs. TLGT: Which Stock Is the Better Value Option?
AGN vs. TLGT: Which Stock Should Value Investors Buy Now? http://www.zacks.com/stock/news/312239/agn-vs-tlgt-which-stock-should-value-investors-buy-now?cid=CS-ZC-FT-312239 Jul 19, 2018 - AGN vs. TLGT: Which Stock Is the Better Value Option?
Ironwood Begins New Phase III Study to Expand Linzess Label http://www.zacks.com/stock/news/311847/ironwood-begins-new-phase-iii-study-to-expand-linzess-label?cid=CS-ZC-FT-311847 Jul 17, 2018 - Ironwood (IRWD) commences a phase IIIb study in order to add a couple of new symptoms like bloating and discomfort associated with IBS-C to Linzess' label.
Here's How Teva Pharmaceuticals Pulled Off a 28.3% Gain in the First Half of 2018 https://www.fool.com/investing/2018/07/15/heres-how-teva-pharmaceuticals-pulled-off-a-283-ga.aspx?source=iedfolrf0000001 Jul 15, 2018 - Demand for generic drugs is on the rise, and investors are convinced the trend will keep this profitable company moving in the right direction.
Here's Why Aurinia Pharmaceuticals Inc. Gained 32.2% in the First Half of 2018 https://www.fool.com/investing/2018/07/14/heres-why-aurinia-pharmaceuticals-inc-gained-322-i.aspx?source=iedfolrf0000001 Jul 14, 2018 - An additional indication for the company's lead candidate has been a big source of encouragement.
Novartis Looks to Exit Antibacterial, Antiviral Program http://www.zacks.com/stock/news/311521/novartis-looks-to-exit-antibacterial-antiviral-program?cid=CS-ZC-FT-311521 Jul 13, 2018 - Per media sources, Novartis is looking to exit its antibacterial and antiviral research program, and cut its headcount.
Top Analyst Reports for Union Pacific, 21st Century Fox & BP http://www.zacks.com/research-daily/171285/top-analyst-reports-for-union-pacific-21st-century-fox-bp?cid=CS-ZC-FT-171285 Jul 10, 2018 - Top Analyst Reports for Union Pacific, 21st Century Fox & BP
How to Invest in Pharmaceutical Stocks: A Beginner's Guide https://www.fool.com/investing/2018/07/03/how-to-invest-in-pharmaceutical-stocks-a-beginn.aspx?source=iedfolrf0000001 Jul 03, 2018 - Here's all you need to start investing in pharmaceutical stocks today.

Pages: 1...56789101112131415...34

<<<Page 10>